Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 46851-46900 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05483868
A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer
PHASE1Recruiting
55 participants
Started: Sep 26, 2022 · Completed: Apr 30, 2027
7 conditions1 sponsor10 locations
NCT06290986
Pyrocardan® Implant Arthroplasty or LRTI for Trapeziometacarpal Osteoarthritis
NARecruiting
64 participants
Started: Sep 26, 2022 · Completed: Sep 30, 2025
2 conditions1 sponsor1 location
NCT05428852
Keto-Brain:Investigating the Use of Ketogenic Diets in Brain Metastases
NARecruiting
24 participants
Started: Sep 26, 2022 · Completed: Oct 31, 2026
1 condition1 sponsor1 location
NCT05546684
The Effect of Foot Bath on Postoperative Sleep Quality in Patients Undergoing Transurethral Resection
NARecruiting
82 participants
Started: Sep 26, 2022 · Completed: Dec 25, 2023
1 condition1 sponsor1 location
NCT05327504
Written Exposure Therapy for Veterans With SUD and PTSD
NARecruiting
170 participants
Started: Sep 26, 2022 · Completed: Jun 30, 2027
2 conditions1 sponsor1 location
NCT05555095
Examining Digital Health Care Delivery Models Through Medicaid Collaborative
N/ARecruiting
19,331 participants
Started: Sep 26, 2022 · Completed: Dec 31, 2028
3 conditions1 sponsor1 location
NCT05623982
A Study of GNC-038 Injection in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
PHASE1/PHASE2Recruiting
40 participants
Started: Sep 26, 2022 · Completed: Dec 31, 2027
1 condition3 sponsors3 locations
NCT05598398
NPWTi on Closure of Chronic Pressure Sores
PHASE4Recruiting
62 participants
Started: Sep 26, 2022 · Completed: Oct 31, 2025
1 condition2 sponsors1 location
NCT05542056
Urinary Prostaglandin as a Potential Predictive Marker for Thiazide-induced Hyponatremia
N/ARecruiting
232 participants
Started: Sep 26, 2022 · Completed: Jul 31, 2026
1 condition1 sponsor3 locations
NCT04757116
Post-Market Study to Assess iTind Safety in Comparison to UroLift
NARecruiting
206 participants
Started: Sep 26, 2022 · Completed: Dec 31, 2030
1 condition1 sponsor18 locations
NCT06028919
Power Versus Temperature Controlled Ablation for Treatment of VT
NARecruiting
64 participants
Started: Sep 26, 2022 · Completed: Mar 1, 2026
1 condition3 sponsors2 locations
NCT05983458
SAfe and Fast Discharge With Acurate Valve in Low Risk tavI Patients
NARecruiting
80 participants
Started: Sep 26, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05168839
Intraoperative Indocyanine Green Fluorescence Angiography in Colorectal Surgery to Prevent Anastomotic Leakage
PHASE3Recruiting
1,010 participants
Started: Sep 26, 2022 · Completed: Oct 31, 2025
1 condition1 sponsor32 locations
NCT06160128
Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA)
N/ARecruiting
400,000 participants
Started: Sep 26, 2022 · Completed: Sep 30, 2027
3 conditions3 sponsors1 location
NCT04839497
Multicenter Trial Evaluating the Safety and Efficacy of Autologous Volar Fibroblast Injection Into the Terminal Limb of Amputees.
PHASE2Recruiting
20 participants
Started: Sep 26, 2022 · Completed: Jan 1, 2027
1 condition2 sponsors1 location
NCT05507879
TRPC6 Characterization to Predict and Prevent Chemotherapy Related Cardiomyopathy and Heart Failure With Breast Cancer
N/ARecruiting
300 participants
Started: Sep 26, 2022 · Completed: Sep 1, 2027
3 conditions1 sponsor2 locations
NCT05584501
ETE Interventions in the Dental Setting
NARecruiting
153 participants
Started: Sep 26, 2022 · Completed: Oct 31, 2024
1 condition2 sponsors2 locations
NCT05693493
Can Proprioceptive Knee Brace Improve Functional Outcome Following TKA?
NARecruiting
30 participants
Started: Sep 26, 2022 · Completed: Sep 30, 2024
1 condition1 sponsor1 location
NCT05390892
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes
PHASE4Recruiting
6,000 participants
Started: Sep 26, 2022 · Completed: Mar 1, 2029
2 conditions2 sponsors8 locations
NCT05390580
Neuromodulation Using Vagus Nerve Stimulation Following Ischemic Stroke as Therapeutic Adjunct
NARecruiting
80 participants
Started: Sep 26, 2022 · Completed: Dec 23, 2024
1 condition1 sponsor1 location
NCT05483491
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
PHASE1Recruiting
30 participants
Started: Sep 26, 2022 · Completed: Dec 31, 2028
4 conditions3 sponsors2 locations
NCT05548348
First-line Furmonertinib in Advanced NSCLC Patients With EGFR Uncommon Mutation
PHASE2Recruiting
30 participants
Started: Sep 26, 2022 · Completed: Oct 31, 2025
4 conditions3 sponsors3 locations
NCT06066008
Safety and Efficacy Study of Novel Gene Therapy ZM-01 for X-linked Retinoschisis Patients
EARLY_PHASE1Recruiting
9 participants
Started: Sep 25, 2022 · Completed: Oct 31, 2027
1 condition1 sponsor1 location
NCT06293560
Microphthalmia, Anophthalmia, and Coloboma Genetic Epidemiology in Children
N/ARecruiting
3,000 participants
Started: Sep 25, 2022 · Completed: Sep 30, 2027
3 conditions3 sponsors1 location
NCT05565209
Left Atrial Appendage Closure Registry of Henri Mondor Hospital
N/ARecruiting
250 participants
Started: Sep 24, 2022 · Completed: Sep 14, 2026
1 condition1 sponsor1 location
NCT05549037
Effect of Time-of-Day (ToD) for Immunochemotherapy on PFS in NSCLC
PHASE3Recruiting
210 participants
Started: Sep 23, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04965064
Trial of Neratinib Plus Capecitabine in Subjects with HER2-Negative Metastatic Breast Cancer with Brain Metastases and Abnormally Active HER2 Signaling
PHASE2Recruiting
22 participants
Started: Sep 23, 2022 · Completed: Sep 1, 2027
1 condition1 sponsor1 location
NCT05464719
A Phase II Study of Loncastuximab Tesirine as Consolidation Strategy in Patients With LBCL in PR After CAR T-cell Therapy
PHASE2Recruiting
30 participants
Started: Sep 23, 2022 · Completed: Jan 30, 2026
2 conditions1 sponsor1 location
NCT05570110
Enoxolone in Major Depression - Biomarker-outcome Relationship
PHASE1/PHASE2Recruiting
60 participants
Started: Sep 23, 2022 · Completed: Mar 31, 2025
1 condition2 sponsors1 location
NCT06683261
Real-life Evaluation of the Efficacy of Biologicals in Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP)
N/ARecruiting
300 participants
Started: Sep 23, 2022 · Completed: Dec 31, 2026
2 conditions1 sponsor8 locations
NCT05538286
Transcranial Ultrasound Via Sonolucent Cranioplasty After Minimally Invasive Intracerebral Hemorrhage Evacuation
NARecruiting
25 participants
Started: Sep 23, 2022 · Completed: Sep 30, 2025
2 conditions1 sponsor1 location
NCT05365035
A Phase II Study of Cladribine and Low Dose Cytarabine in Combination With Venetoclax, Alternating With Azacitidine and Venetoclax, in Patients With Higher-risk Myeloproliferative Chronic Myelomonocytic Leukemia or Higher-risk Myelodysplastic Syndromes With Excess Blasts
PHASE2Recruiting
60 participants
Started: Sep 23, 2022 · Completed: Dec 1, 2025
2 conditions1 sponsor1 location
NCT05546827
PRISAM: Pre-Operative Radiotherapy and Immunotherapy for Sinonasal and Anorectal Melanoma
PHASE2Recruiting
40 participants
Started: Sep 23, 2022 · Completed: Jul 31, 2028
2 conditions1 sponsor1 location
NCT05039281
Atezolizumab and Cabozantinib for the Treatment of Recurrent Glioblastoma
PHASE1/PHASE2Recruiting
6 participants
Started: Sep 23, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05109364
Terazosin and Parkinson's Disease Extension Study
PHASE2Recruiting
15 participants
Started: Sep 23, 2022 · Completed: Nov 1, 2025
3 conditions1 sponsor1 location
NCT05502133
Identification of Acute Intermittent Porphyria Modifying Genes
N/ARecruiting
150 participants
Started: Sep 23, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05306743
PRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD.
NARecruiting
126 participants
Started: Sep 23, 2022 · Completed: Dec 31, 2026
1 condition4 sponsors3 locations
NCT05327114
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
PHASE2/PHASE3Recruiting
201 participants
Started: Sep 23, 2022 · Completed: Sep 30, 2028
1 condition1 sponsor95 locations
NCT05809999
IBD Neoplasia Surveillance RCT
NARecruiting
1,952 participants
Started: Sep 23, 2022 · Completed: Feb 28, 2026
3 conditions1 sponsor11 locations
NCT05345392
Brain, Emotions, and Mind-Wandering
NARecruiting
140 participants
Started: Sep 23, 2022 · Completed: Feb 28, 2027
1 condition2 sponsors1 location
NCT05443646
Consolidation Serplulimab Following Concurrent Chemoradiotherapy for LS-SCLC Patients
PHASE2Recruiting
55 participants
Started: Sep 23, 2022 · Completed: Jun 30, 2025
1 condition1 sponsor2 locations
NCT05378581
Use of Virtual Reality Mask During Blood and Skin Allergic Tests in 7 to 13 Children
NARecruiting
300 participants
Started: Sep 23, 2022 · Completed: Sep 30, 2026
4 conditions1 sponsor2 locations
NCT05543616
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
PHASE2/PHASE3Recruiting
4,292 participants
Started: Sep 23, 2022 · Completed: Jun 16, 2026
3 conditions2 sponsors134 locations
NCT05844514
COlorectal BReath Analysis (COBRA2)
N/ARecruiting
720 participants
Started: Sep 23, 2022 · Completed: Dec 1, 2026
1 condition6 sponsors5 locations
NCT05944354
Wearable Spine Health System for Military Readiness
N/ARecruiting
400 participants
Started: Sep 23, 2022 · Completed: Dec 31, 2032
2 conditions2 sponsors10 locations
NCT05497804
Combination Treatment Therapy Approaches for the Treatment of High-Risk Multiple Myeloma, REACH Trial
PHASE2Recruiting
75 participants
Started: Sep 22, 2022 · Completed: Nov 20, 2028
2 conditions2 sponsors3 locations
NCT05286619
A Study of Pembrolizumab (MK-3475) Plus Platinum and Gemcitabine as First Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (PIPER)
PHASE2Recruiting
63 participants
Started: Sep 22, 2022 · Completed: Dec 31, 2028
1 condition8 sponsors1 location
NCT05805462
The Euro-CRAFT Registry
N/ARecruiting
671 participants
Started: Sep 22, 2022 · Completed: Sep 22, 2030
1 condition2 sponsors19 locations
NCT05471414
Whole-Food Plant-Based Diet to Control Weight and MetaboInflammation in Overweight/Obese Men With Prostate Cancer
NARecruiting
60 participants
Started: Sep 22, 2022 · Completed: Dec 31, 2026
1 condition4 sponsors3 locations
NCT05343988
Percutaneous Neurostimulation to Treat Paroxysmal Sympathetic Hyperactivity in Children
NARecruiting
20 participants
Started: Sep 22, 2022 · Completed: Nov 30, 2026
1 condition1 sponsor1 location